Tokyo, Japan

Ken Shimada


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ken Shimada: Innovator in Pharmaceutical Solutions

Introduction: Ken Shimada is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the pharmaceutical industry. With a focus on enhancing the solubility of poorly soluble drugs, Shimada’s work has led to innovative solutions that can potentially transform drug delivery and effectiveness.

Latest Patents: Ken Shimada holds a notable patent that centers around a pharmaceutical composition designed to improve the solubility and dissolution properties of a poorly-soluble drug. This patent comprises a poorly-soluble drug along with polyvinyl alcohol, which has a saponification degree between 63 mol % and 67 mol %. This innovative approach aims to enhance the bioavailability of various medications, providing patients with more effective treatment options.

Career Highlights: Ken Shimada is currently employed at Astellas Pharma GmbH, where he continues to develop groundbreaking solutions in pharmaceutical science. His dedication to innovation has earned him recognition in the industry, as he actively contributes to advancing technologies that improve drug formulations.

Collaborations: Throughout his career, Shimada has collaborated with esteemed colleagues, including Takatsune Yoshida and Hiroyuki Kojima. These partnerships exemplify the importance of teamwork and collaboration in the realm of scientific research and patent development, driving forward the boundaries of pharmaceutical innovations.

Conclusion: Ken Shimada represents the spirit of innovation within the pharmaceutical sector. His patented compositions pave the way for improved drug formulations, demonstrating the significant impact of inventive thinking on healthcare solutions. As he continues his work at Astellas Pharma GmbH, the future holds promise for further advancements emanating from his research and collaborations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…